22 May 2013
Keywords: frisc, ii, data, support, prolonged, fragmin, use
Article | 01 September 1999
Final data from the FRISC II (FRagmin during InStability in Coronaryartery disease) study have confirmed the efficacy of Pharmacia & Upjohn's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.